Report
Moderna stock forecast to plunge 60% after a run since mid-August
CNBC reports that Citi now sees Moderna stock plunging 60%, despite its run since mid-August. Citi analyst Geoff Meacham downgraded the biotech to sell.
TLDR
CNBC reports that Moderna stock has been on a tear since mid-August, but Citi now sees it plunging 60%. Citi analyst Geoff Meacham downgraded the biotech to sell.
Combined views
91.5K
4 Sources, first seen ago
